Record-setting Bio-Silicon Chip is first to create Synthetic DNA at IT Scale for Molecular Computing solutions addressing growing demands of the AI Era

AtlasBase today announced its molecular computing platform, powered by Thalia, a new scalable chip that delivers petabyte-scale synthetic DNA creation. With 5.6 billion electro-chemical synthesis sites, Thalia represents a 700x increase in scale over previously available DNA synthesis chips, overcoming a key technical barrier to bringing molecular computing to IT scale. Thalia forms the heart of the AtlasBase molecular computer, providing the scalable engine to drive molecular data storage and molecular compute/processing solutions for the growing compute, data management, and power constraints of the AI era.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922579834/en/

AtlasBase is a molecular computing company pioneering the next generation of enterprise IT data infrastructure. Learn more at www.atlasbase.com

As AI drives organizations to generate, consume, and retain unprecedented volumes of data, legacy infrastructure is hitting its practical limits. The next generation of enterprise computing requires a new substrate for storing and processing information, one that complements, rather than replaces, traditional silicon. AtlasBase answers this need with a molecular computing platform that uses synthetic DNA for both data storage and in-memory computation, enabling specialized processing on data within the same molecular medium.

Built by a team with more than 15 years of experience advancing commercial DNA synthesis, AtlasBase’s semiconductor DNA synthesis technology is designed to overcome one of the field’s biggest challenges: making synthetic DNA creation scalable. The result is an infrastructure that lets enterprises archive massive datasets in synthetic DNA while extending molecular computing to solve highly complex computational problems on that same data, without requiring it to be moved, shuffled, or translated between storage and compute.

“For 2 billion years, DNA has flourished as nature’s data platform, an incredibly capable structure for processing the information that defines every living thing,” said Jeff Treuhaft, CEO of AtlasBase. “We’re now harnessing that same architecture for computing at a scale that was never before possible. AtlasBase is delivering a new enterprise data layer where “in memory” computation works efficiently, bringing molecular computing into commercial reality at IT scale.”

Designed for the Next Generation of Enterprise Data

As organizations adopt AI, digitize operations, and preserve increasingly valuable data assets, enterprise infrastructure must evolve to support data that is not only larger in volume, but more critical to future business operations. AtlasBase is designed to complement traditional computing infrastructure by providing a molecular platform for long-term data preservation and specialized computational workloads, enabling organizations to securely retain, access, and derive value from data over decades.

AtlasBase brings together three foundational technologies into a single enterprise platform:

• Semiconductor-based DNA Synthesis: Thalia is AtlasBase’s proprietary CMOS DNA synthesis chip, with 5.6 billion electro-chemical synthesis sites to create synthetic DNA at unprecedented scale. Built using existing mass manufacturing technologies, Thalia can scale up and scale out to make molecular infrastructure commercially practical for enterprise IT and meet the demands of today’s hyperscale data center designs.
• Molecular Data Storage: Efficiently archive massive volumes of enterprise data into synthetic DNA for incredibly dense, extremely durable, long-term preservation.
• Molecular Compute (processing): Apply DNA-based computation to specialized optimization and data search problems that benefit from efficient massively parallel processing.

Molecular Storage and Compute Applications

AtlasBase applications span industries and workloads. In entertainment, where studios manage vast and continually growing libraries of valuable digital content, molecular storage offers an immediate opportunity to address the long-standing challenge of preserving those assets for generations, while molecular compute introduces new possibilities for how data can be searched, processed, and put to use.

“The entertainment industry has searched for a truly sustainable way to preserve our iconic film and television shows for decades,” said Bill Baggelaar, former CTO of Sony Pictures Entertainment and co-author of the MovieLabs 2030 Vision. “Molecular storage can fundamentally change that by preserving our most valuable creative assets for generations, without the constant migration and maintenance that plagues today’s solutions. What’s especially exciting about AtlasBase is that it goes beyond archiving: it turns DNA into a molecular platform capable of both storing data and computing on it in entirely new ways.”

“For more than 30 years, scientists have explored how DNA can serve as a medium for information storage and computation,” said Shuki Bruck, Gordon and Betty Moore Professor Emeritus at Caltech. “AtlasBase is working on the data-center-scale infrastructure that could help translate these capabilities into systems relevant to enterprise IT and AI-driven demand.”

Availability

AtlasBase is offering Early Access Programs for Molecular Compute and Molecular Data Storage with select partners and customers across its molecular computing platform. Initial applications include digital preservation, enterprise archives, and complex optimization challenges across industries such as media, financial services, logistics, manufacturing, scientific research, and resource exploration. To learn more, visit: https://www.atlasbase.com/.

About AtlasBase

AtlasBase is a molecular computing company pioneering the next generation of enterprise IT data infrastructure. Building on its breakthrough innovations in DNA synthesis, AtlasBase combines proprietary bio-silicon, electrochemical, semiconductor based DNA synthesis, molecular data storage, and molecular computing into a unified platform to help organizations securely preserve, access, and compute on data at unprecedented scale. Founded in 2025 and headquartered in San Francisco, AtlasBase is creating a new enterprise data layer that complements traditional IT architectures to help organizations prepare for the next generation of AI-driven, data-intensive computing. AtlasBase is backed by leading investors, including ARCH Venture Partners, Bezos Expeditions, Deerfield, Earth Foundry, and Twist Bioscience. Learn more at www.atlasbase.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260922579834/en/